PCK1 and SLC22A2 gene variants associated with response to metformin treatment in type 2 diabetes.

PCK1 and SLC22A2 gene variants associated with response to metformin treatment in type 2 diabetes.

Type 2 diabetes (T2D) is a chronic disorder affecting 462 million worldwide, often managed with metformin as first-line treatment. However, metformin's response varies among individuals, including up to 30% experiencing serious adverse drug reactions (ADRs) and 20-50% inefficacy. These differen...

Full description

Saved in:
Bibliographic Details
Main Authors: Sophie St-Amour, Laurence Tessier, Janie Harnois, Catherine Allard, Alexandre Lavoie, Philippe Caron, Luigi Bouchard, Patrice Perron, Karine Tremblay
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0305511
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items